The APOE ε4 allele, widely recognized as the primary risk factor for Alzheimer’s disease (AD), induces broad molecular and cellular changes linked to AD phenotypes, prominently enhancing amyloid-beta (Aβ) deposition in the brain (Lin et al., 2018). This evidence concerns the gene APOE and Alzheimer disease.